GCP Compliance Oversight Manager, FSP
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
PTC Therapeutics is a global commercial biopharmaceutical company dedicated to extending life’s moments for children and adults living with rare diseases. We foster an inclusive culture where everyone feels valued, respected, and empowered.
The Manager, Quality Assurance – GxP Auditing (GMP-GDP) is responsible for executing GxP Quality Assurance (QA) auditing functions, with a focus on Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) quality systems governing compliance programs for commercial and clinical activities. This role involves collaboration with internal cross-functional teams to evaluate CMC processes, procedures, and activities for adherence to industry standards, regulatory guidelines, and company SOPs. The incumbent will contribute to the continuous improvement of a risk-based audit program, qualification requirements, and the inspection management process. Additionally, the role supports and/or conducts internal and external GMP and GDP compliance audits of Contract Manufacturing Organizations (CMOs), vendors, laboratories, and submission documents, and assists in inspection readiness and QA activities.
PTC Therapeutics is a global commercial biopharmaceutical company with a commitment to extending life’s moments for children and adults living with a rare disease. We cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.
Visit our website to learn more about our company and culture! Site: www.ptcbio.com
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.